OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
34
Results
Show all
Save search
Copy query
Show results for
Unknown
(34)
Publication Date
Release Date
2018
(29)
2023
(2)
2021
(2)
2015
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.
Not available
S-EPMC4429174
|
biostudies-literature
Cite
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.
Not available
S-EPMC8417875
|
biostudies-literature
Cite
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
Not available
S-EPMC8384401
|
biostudies-literature
Cite
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Not available
S-EPMC10367935
|
biostudies-literature
Cite
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Not available
S-EPMC9905474
|
biostudies-literature
Cite
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
Not available
S-EPMC6075717
|
biostudies-literature
Cite
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
Not available
S-EPMC6143179
|
biostudies-literature
Cite
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Not available
S-EPMC5966039
|
biostudies-literature
Cite
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Not available
S-EPMC5892207
|
biostudies-literature
Cite
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
Not available
S-EPMC5916807
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets